Primary diffuse large B-cell lymphomas of the bone: prognostic relevance of protein expression and clinical factors

Human Pathology

Volumn 39, Issue 9, 2008, Pages 1323-1330

  Adams, Heiner ^a   Tzankov, Alexandar ^a   d'Hondt, Steven ^a   Jundt, Gernot ^a   Dirnhofer, Stephan ^a   Went, Philip ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Large B cell lymphoma; MUM1; Primary bone lymphoma; Tissue microarray

Indexed keywords

ANTINEOPLASTIC AGENT; CD44V ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; INTERFERON REGULATORY FACTOR 4; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN BCL 6; SYNDECAN 1;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; BONE CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CHILD; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALE; OVERALL SURVIVAL; PATHOLOGY; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STATISTICAL MODEL; TISSUE MICROARRAY; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADULT; AGED, 80 AND OVER; BONE NEOPLASMS; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENE EXPRESSION; GENE REARRANGEMENT, B-LYMPHOCYTE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERFERON REGULATORY FACTORS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 49049117994     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.01.004     Document Type: Article

References (34)

1. Ramadan K., Shenkier T., Sehn L., et al. A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol 18 (2007) 129-135
2. Dubey P., Ha C.S., Besa P.C., et al. Localized primary malignant lymphoma of bone. Int J Radiat Oncol Biol Phys 37 (1997) 1087-1093
3. Lopez-Guillermo A., Colomo L., Jimenez M., et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 23 (2005) 2797-2804
4. Unni K.K., and Hogendoorn P.C. Malignant lymphoma. In: Fletcher C.D.M., et al. (Ed). Pathology & Genetics Tumors of Soft Tissues and Bone (2002), IARC Press, Lyon, France 306-308
5. Glotzbecker M.P., Kersun L.S., Choi J.K., et al. Primary non-Hodgkin's lymphoma of bone in children. J Bone Joint Surg Am 88 (2006) 583-594
6. Unni K.K., Inwards C.Y., Bridge J.A., et al. Tumors of the Bones and Joints (2005), ARP Press, Silver Spring (Md) 231-240
7. Heyning F.H., Hogendoorn P.C., Kramer M.H., et al. Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia 13 (1999) 2094-2098
8. Beal K., Allen L., and Yahalom J. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients. Cancer 106 (2006) 2652-2656
9. Durr H.R., Muller P.E., Hiller E., et al. Malignant lymphoma of bone. Arch Orthop Trauma Surg 122 (2002) 10-16
10. Horsman J.M., Thomas J., Hough R., et al. Primary bone lymphoma: a retrospective analysis. Int J Oncol 28 (2006) 1571-1575
11. Brousse C., Baumelou E., and Morel P. Primary lymphoma of bone: a prospective study of 28 cases. Joint Bone Spine 67 (2000) 446-451
12. Achemlal L., Mikdame M., Nouijai A., et al. Dramatical improvement of chemoresistant bone lymphoma with rituximab. Clin Rheumatol 25 (2006) 394-395
13. Christie D.R., Barton M.B., Bryant G., et al. Osteolymphoma (primary bone lymphoma): an Australian review of 70 cases. Australasian Radiation Oncology Lymphoma Group (AROLG). Aust N Z J Med 29 (1999) 214-219
14. Shannon J.A., Bell D.R., Levi J.A., et al. Bone presentation of non-Hodgkin's lymphoma: experience at the Royal North Shore Hospital, Sydney; highlighting primary bone lymphoma. Aust N Z J Med 24 (1994) 701-704
15. Ostrowski M.L., Unni K.K., Banks P.M., et al. Malignant lymphoma of bone. Cancer 58 (1986) 2646-2655
16. Deshmukh C., Bakshi A., Parikh P., et al. Primary non-Hodgkin's lymphoma of the bone: a single institution experience. Med Oncol 21 (2004) 263-267
17. Barbieri E., Cammelli S., Mauro F., et al. Primary non-Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for Stage I and Stage II. Int J Radiat Oncol Biol Phys 59 (2004) 760-764
18. de Leval L., Braaten K.M., Ancukiewicz M., et al. Diffuse large B-cell lymphoma of bone: an analysis of differentiation-associated antigens with clinical correlation. Am J Surg Pathol 27 (2003) 1269-1277
19. Gianelli U., Ponzoni M., Moro A., et al. Mutations of the 5¢ noncoding region of the BCL-6 gene in primary bone lymphomas. Ann Hematol 82 (2003) 691-695
20. Huebner-Chan D., Fernandes B., Yang G., et al. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone. Mod Pathol 14 (2001) 1000-1007
21. Zinzani P.L., Carrillo G., Ascani S., et al. Primary bone lymphoma: experience with 52 patients. Haematologica 88 (2003) 280-285
22. Antillon F., Behm F.G., Raimondi S.C., et al. Pediatric primary diffuse large cell lymphoma of bone with t(3;22)(q27;q11). J Pediatr Hematol Oncol 20 (1998) 552-555
23. Hans C.P., Weisenburger D.D., Greiner T.C., et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103 (2004) 275-282
24. Capello D., Vitolo U., Pasqualucci L., et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood 95 (2000) 651-659
25. Tzankov A., Went P., Zimpfer A., et al. Tissue microarray technology: principles, pitfalls and perspectives-lessons learned from hematological malignancies. Exp Gerontol 40 (2005) 737-744
26. Katzenberger T., Petzoldt C., Holler S., et al. The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma. Blood 107 (2006) 3407
27. Obermann E.C., Went P., Zimpfer A., et al. Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis. BMC Cancer 5 (2005) 162
28. Le C.T. A solution for the most basic optimization problem associated with an ROC curve. Stat Methods Med Res 15 (2006) 571-584
29. Zimpfer A., Schonberg S., Lugli A., et al. Construction and validation of a bone marrow tissue microarray. J Clin Pathol 60 (2007) 57-61
30. Moller M.B., Pedersen N.T., and Christensen B.E. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation-a population-based study of 1575 cases. Br J Haematol 124 (2004) 151-159
31. Stansfeld A.G., Diebold J., Noel H., et al. Updated Kiel classification for lymphomas. Lancet 1 (1988) 292-293
32. Huang J.Z., Sanger W.G., Greiner T.C., et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood 99 (2002) 2285-2290
33. Barrans S.L., Evans P.A., O'Connor S.J., et al. The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome. Clin Cancer Res 9 (2003) 2133-2139
34. Falini B., Fizzotti M., Pucciarini A., et al. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 95 (2000) 2084-2092